MATINAS BIOPHARMA HOLDINGS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -21,067.4% | -19,343.4% |
| FY2020 | — | -15,288.4% | -14,177.0% |
| FY2021 | — | -74,954.5% | -70,554.5% |
| FY2022 | — | -771.3% | -658.6% |
| FY2023 | — | -2,168.4% | -2,093.2% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | — | -21,067.4% | -19,343.4% |
| FY2020 | — | -15,288.4% | -14,177.0% |
| FY2021 | — | -74,954.5% | -70,554.5% |
| FY2022 | — | -771.3% | -658.6% |
| FY2023 | — | -2,168.4% | -2,093.2% |